Biondvax Pharmaceuticals Overview
Biondvax Pharmaceuticals Discounted Cash Flow
DCF Analysis for BVXV.
Get informed when a big investor buys or sells
+ FollowFair Value
$1.86
Current Fair Value
$1.86
↑ 37.0% Upside
Undervalued by 37.0% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison